Home
 About JSR Genetics
 Boars
 Gilts
 A I
 Health and Welfare
 International
 Research
 Conference Papers
 News Archives
 JSR Technical Brief

 in Chinese


JSR Farming Group
 JSR Farming Group
 JSR Arable
 JSR Pig Production
 Staff Development
 JSR Buying Group
 JSR Farming News
 Careers@JSR
 Links
 How to find us
 Contact JSR



Paper presented at the 16th Annual JSR Technical Conference

 
AGP Ban: An Opportunity for Profit or Loss
Paul Toplis, Technical Director, Primary Diets

Paul Toplis Paul Toplis

After graduating Paul joined RHM Agriculture as assistant nutritionist working on ruminant, pigs and poultry nutrition, becoming National Pig Nutritionist in 1976 and Chief Nutritionist 4 year later. Since 1983 he has traveled widely advising on pig nutrition. Paul was part of the team which led SCA Nutrition to be the first ever livestock feed company to win the Queen’s Award for Export Achievement.
       In 1996, with 3 fellow directors, Paul formed Primary Diets Ltd which has become one of the market leaders in specialist piglet diet manufacture, trading throughout the UK and Europe. He has spoken at conferences and scientific meetings in the USA, Canada, Denmark, Spain, Italy, Greece, Cyprus, South Africa, Australia and New Zealand, and at many farmers’ meetings in the UK.
       Paul is also involved in training stockpeople and advisory visits to pig units. Paul has served for over 20 years on the Agricultural Industries Federation (formerly UKASTA) Legal Affairs & Scientific Committee.

Contents

Antimicrobial resistance has become a global health problem (animal and human). Two expert workshops run by FAO/WHO/OIE reported that there was clear evidence of adverse human health consequences due to resistant organisms resulting from non human usage of antimicrobials.

Human health consequences include:

  • Infections which would otherwise not have occurred.
  • Increased frequency of treatment failure (including death).
  • Increased severity of infections.

There are 1,415 micro-organisms known to cause disease in humans and 60% of these are ZOONOTIC (capable of being transmitted from animals to man). This information is all the more alarming when we are told that resistance genes are flowing freely between animal and human bacteria. A significant overlap exists between animal and human bacterial reservoirs of antimicrobial resistance. It seems that antimicrobials not only select for resistance to themselves, but also a wide range of other antimicrobials by the mechanism of co-selection. One antimicrobial with no medical use whatsoever can cause an increase in resistance to other antimicrobials that are strategic human medicines. A relevant example of this would be the spread of Vancomycin resistant Enterococci as a result of the use of Avotan (Avoparcin) as a growth promoter in livestock (Witte, W, 2000). Resistant genes travelled through the food chain to the human population.

These are the experiences that have led the EC to apply the ‘Precautionary Principle’, rather than a risk assessment approach. Some authorities have argued for a risk assessment approach where the benefits from individual AGP’s can be set against the risks to human health. For example Flavophospholipol is thought to interfere with the plasmid bridge (pylus) which is prerequisite for genetic transfer of resistance (Oostenbach, PJG. 2005). Could Flavophospholipol make a comeback as an AGP which reduces antibiotic resistance?

They are going – will we miss them?
Whenever reviews of experiments comparing AGP’s with a negative control have been carried out with true scientific rigour, they have been unanimous in concluding AGP’s improve pig performance.

It is possible for some producers to carry out a single farm trial and convince themselves that AGP’s do not work and are not cost effective. The sheer weight of evidence behind AGP review results makes them amongst the most reliable predictions we have in pig production. They all predict improved performance, highly cost effective improvements in daily gain and feed conversion ratio.

If AGP’s are going, then producers must do one of three things:-
  • Replace them
  • Do nothing
  • Upgrade Health (restock)

An Opportunity for Loss
Be afraid. Be very afraid! Without AGP’s, almost all pig producers in the UK will suffer some degree of lost performance resulting in an increased cost of production. Let me illustrate this with a typical result at the University of Leeds where the removal of the AGP from nursery diets alone reduced the nursery exit weight from 12.9 kg to 12.1 kg. All nursery diets contained Zinc Oxide at 3.1 kg/tonne for 14 days post weaning. Valuing 1 kg at 50p for the weaner and 75p for live slaughter weight, the value of lost performance is 40p (0.8 kg x 50p) for the pigs sold as weaners and 60p (0.8 kg x 75p) for slaughter pigs.

Now, for all those producers who want to tell me that the pigs would compensate after the nursery stage and not lose 60p, let me assure you that when we have followed pigs to slaughter at the University of Leeds, the loss at the end of nursery has increased two to threefold by slaughter, despite equal treatment from the end of the nursery period. (Miller H, et al. 2005).

Pigs do not compensate, they fall further behind, so much so that the predicted 60p loss at slaughter, from AGP removal from nursery diets alone, becomes £1.20 to £1.80/pig. These are estimates of the likely losses based on our removing AGP and making no attempt to replace it in nursery diets. Other workers have predicted losses of the same magnitude (£1/pig – Blanchard. 72p/pig – N Kjedsen).

Doing nothing is not an option! Doing nothing is our greatest opportunity for a loss!

Danish Experience – Distraction or Guide?
When AGP’s were removed from Danish pig feed, diarrhoea was recorded on 37% of Danish pig units, with only 26% responding to changes in medication and management. Eleven percent of Danish pig herds failed to respond to measures at their disposal.

These experiences of Danish producers are not as helpful as some would have us believe. On the one hand, they had less access to routine veterinary medicine, especially therapeutic levels of Zinc Oxide and so they encountered more post weaning diarrhoea than I expect to be the case in the UK. For this reason, I believe the Danish experience exaggerates the problems we will face. On the other hand, the much quoted losses of 72p/pig were not for pigs with the AGP removed, but for pigs with the AGP replaced by alternatives. The loss of 72p/pig would have been much higher if AGP’s had simply been removed. Doing nothing is not an option, except for losing money!

REPLACE – the cost effective option
A few producers will have sufficiently high health to allow them to do nothing when AGP’s are removed. Most producers must replace AGP’s or face increased cost of production.

Seeking Replacements
The search for replacements has been severely hampered by a lack of understanding of how AGP’s work. It is widely assumed that AGP’s act mainly through their effect on intestinal microflora. With less than 10% of intestinal microflora identified, there has been little chance of fully understanding AGP’s mode of action. It is postulated that AGP’s benefit livestock through a reduction in the total number of intestinal micro-organisms and/or a more favourable balance between beneficial and non-beneficial micro-organisms.

The importance of Intestinal Microflora – Pig interactions
The pig monitors what bacteria are within its gut and reacts to what is there. Pigs grow faster or slower according to what it ‘sees’ in its gut! At least five hundred bacterial species colonise the pigs intestine at 1011 cfu/g intestinal contents. This is ten times more cells than the number of cells in the pig body. The corporate genome of these bacteria represent 2 – 4 million genes compared to the 30 to 40,000 genes present in the pig genome (Hooper, LV et al, 2002). The intestinal microflora have important and differing effects on the pig, including regulation of epithelial cell turnover, competition for ingested nutrients, modification of digestion, competitive exclusion of pathogens, metabolism of mucus secretions and modulation of mucosal immunity (Hooper et al, 2002).

Bacterial species affect these response parameters differently, resulting in a net benefit or detriment to the health and performance of the pig (Gaskins, HR. 2001). Real-time PCR showed that expression of pro-inflammatory cytokines interleukin IL-1 and IL-6 in whole sections of the distal SI was highest following 13 day mono-association with E Coli and lowest in lactobacillus inoculated v germ free pigs (Shirkey TW et al, 2003). Workers have shown that relative expression of intestinal intestinotrophic hormone was increased in lactobacillus inoculated and reduced in E coli inoculated pigs. (Siggers et al, 2003).

Mode of Action
Best guesses as to how AGP’s work have been summarised (Bikker & van der Aar 2005, Bedford 2005), as follows:-

AGP’s directly;
  1. depress microbial growth in the gastro-intestinal tract.
Reduced microbial growth results in;
  1. reduced activation of the intestinal immune system
  2. thinner intestinal wall
  3. increased digestive enzyme output
  4. reduced gut motility
  5. reduced mucin secretion
  6. reduced toxin (eg ammonia and biogenic amune from protein formulation) production
  7. reduced bile salts modification
The outcome is that more nutrients are made available for growth.

Lifetime Performance
Could AGP’s be doing more than simply reducing the number of micro-organisms? Can the gut microflora create effects early in the piglets life which go on to affect lifetime performance? Is there evidence of microbial programming for ongoing improved performance?

There are reported examples of immunological, endocrine and nutritional programming, where postnatal experiences have been shown to have long term effects. Administration of dexamethasone within 1 h of birth, increased weaning weight by 10% compared with control pigs suggest endocrine programming. (Carroll, JA, 2000). Feeding chicks glutamine for the first four days of life had long term effects on villus morphology, evidence of nutritional programming. (Bartell, SM et al, 2004). Early exposure to specific antigens, helping to prevent allergy in adult life infers immunological programming. (Zemann, B et al, 2003).

There is also some evidence suggesting the early colonisation patterns in the intestine have long term effects. Kalliomaki, M et al (2001) found that individuals that developed atopic disease later in life had a reduced ratio of bifidobacteria to clostridia during early development and this led them to conclude that the development of atopic disease is potentially preceded by differences in early intestinal bacterial colonisation.

In the absence of a better understanding, most workers in this area have simply looked for products that will reduce intestinal microbial growth.

Products with Bacteriostatic Properties

Organic acids
Use of various organic acids in pig diets has been reviewed by Partenen and Mroz (1999). Organic acids have long been used as preservatives because of their ability to prevent spoilage by microbial growth.

What makes organic acids so good as preservatives is their ability to enter a bacterial cell. Once inside the alkaline environment of the bacterial cell’s cytoplasm, the organic acid separates (disassociates), releasing it’s acid anion (H+) component, which acidifies the cell contents. As the H+ anion accumulates within the cell, it inhibits microbial enzymes and the distressed cell attempts to return to equilibrium by pumping out the H+ anion. The energy required to eject the H+ anion is thought to weaken the already distressed cell, slowing growth and reproduction. A further benefit then accrues from the increasing amount of H+ anion pumped back out into the intestinal contents as their acidifying effect favours the acid producing bacteria (lactobacilli, bifidobacteria) and inhibits the acid hating bacteria (Salmonella, E Coli, Campylobacter sp). Dietary acidification brings other benefits; improving gastric proteolysis and protein digestibility, the acid anion can also complex with minerals and increase their digestibility.

Organic acids also serve as substrates in intermediary metabolism and therefore have an energy content (Propionic acid has 1.5 times more energy than wheat).

The dual mode of action of organic acids makes them so attractive, at low pH, they do not disassociate, which allows them to enter and disrupt the bacterial cell. At higher pH, the acid disassociates and inhibits alkaline loving bacteria and favours acid loving ones. By combining several organic acids, which disassociate at different pH levels, it is possible to exploit the effects of both modes of action over a larger proportion of the range of pH found in the pigs intestines.

Essential Oils
Essential oils are highly concentrated extracts produced by further refinement of plant extracts (botanicals) by hydro-distillation. Essential oils are used to flavour pig diets to increase their attractiveness to pigs and stockmen. Essential oils are also claimed to have antimicrobial, antioxidant, coccidiostatic and even antiviral properties. (Wenk, C, 2003). Claims are also made for increased digestive enzyme secretion and improved immune function.

Essential oils are standardised products, often based on a blend of plant metabolites such as allylisothiocyanates, thymol, carvacrol, cinnamaldehyde, capsaicin, piperin and others.

In-vitro studies had shown essential oils to have powerful antimicrobial effects. When included in pig diets to flavour them, in accordance with their authorisation, some trials have recorded improved performance over and above the expected improvement from increased appetite alone. (Janroz, D, et al, 2003).

There are reports of synergy between organic acids and essential oils. The synergy is thought to come from the ability of the essential oils to weaken bacterial cell walls, increasing its permeability to the organic acids.

Prebiotics & Probiotics
Prebiotics are short chain carbohydrates which cannot be digested or absorbed by the pig and are therefore available for intestinal microflora. Ileal digestibility of Inulin, (a prebiotic), is only 7.5%, but none can be found in faeces, indicating total fermentation in the hind gut. The end products of fermentation are Short Chain Fatty Acids.

Probiotics are live cultures of acid secreting beneficial bacteria.

Both are thought to act by manipulating the indigenous microflora in the intestine to reduce the risk of proliferation of potential pathogens. Through a variety of mechanisms, they are thought to increase resistance to infection.

Various modes of action have been proposed:-
  1. Enhancement of the physical barrier (modulation of paracellular permeability, mucosal trophic action).
  2. Improved functional barrier (mucosal immunity).
  3. Competitive adhesion to epithelial receptors.
  4. Reduction of intestinal pH.
  5. Modification of bile salts.
  6. Competitive exclusion (colonisation resistance).

Joined Up Antimicrobial Action
The first line of defence is to prevent harmful bacteria from entering the intestines by the oral route. Acidic conditions in the stomach are achieved by the secretion of hydrochloric acid to form a powerful antimicrobial barrier. In newly weaned piglets, this mechanism can be inadequately developed and suspect. Lactic acid originating from the fermentation of lactose by lactic acid bacteria (naturally occurring and Probiotic additives) is helpful but limited by the relatively small amount of bacterial activity in the stomach and proximal small intestine. Anything that increases acid production post weaning (Prebiotic SCFA, Probiotic Lactic Acid) can enhance antimicrobial competence and improve the barrier to orally acquired pathogens.

Colonisation resistance and Competitive exclusion
If a healthy gut is defined as an environment with lower populations of E Coli, Salmonella, Staphylococci, Listeria, Shigella, Veillonella, Brachyspiro (Serpulina) and Clostridia, but higher populations of Lactobacilli, Bifidobacteria and Eubacteria, then any substance found to promote that type of intestinal microflora will be valued. Some prebiotics are selectively fermented by Lactobacilli, Bifidobacteria and Eubacteria, whilst being poorly utilised by the potentially harmful bacteria listed above.

Gut Integrity
It is generally accepted that high villi/crypt depth ratios are indicators of a healthier and more efficient intestinal mucosa. If Prebiotics have a beneficial effect on the gut integrity, it would be expected to show itself in the distal small intestine, at what is thought to be the area with the greatest levels of fermentation. In a recent experiment, ratios were enhanced in proximal and distal sections, but only achieved statistical significance in the distal area. Fermentation was enhanced along the entire small intestine. (Decuypere, J, 2003).

Acid Barrier – Central and Hind Gut
The main end products of bacterial carbohydrate metabolism are acids, short chain fatty acids (SCFA), mainly acetic, propionic and butyric. SCFA are weak organic acids with bacteriostatic properties in common with the organic acids used as preservatives mentioned earlier. SCFA play an important supporting role in the prevention of potentially harmful bacteria escaping the stomach and migrating forward through the small intestine, but more importantly, the reverse flux of harmful bacteria from hind gut to small intestine.

Prebiotics cause increased SCFA production along the gastro-intestinal tract by inducing a shift to a more saccharolytic (carbohydrate fermenting) flora. The presence of fermentable carbohydrates in the pigs diet will reduce protein fermentation, reducing toxic substances such as ammonia, amines, skatol and indole. It is known that increased butyrate concentrations contribute to a healthier intestine because butyric acid is a strong stimulator of the gastrointestinal cell growth, not only for the colonocytes, but also for the enterocytes of the small intestine. (D Pouillard, 2003). Immune cells form part of the intestinal epithelial lining who’s function is to monitor, react and coordinate a response to the components of the intestinal microflora. Pre and probiotics increase the chances of a favourable response to the monitoring process, minimising immune activation with its highly beneficial impact on appetite and nutrient partitioning to growth. Growth responses to Pre and Probiotics achieve statistical significance in the first 14 days after weaning which confirms they can be fast acting in their influences. (Corrent, S, 2002).

Enzymes
A review by Bedford and Schulze (1998) is a useful place to start for anyone wishing further information on enzymes. Addition of enzymes to a pigs diet may supplement the process of digestion which has the double benefit of increasing nutrient availability to the pig whilst reducing the availability of nutrients to the intestinal microflora.

Immune modulators
There are immunologically active compounds which may beneficially effect the immune system of the pig. They include mainly antibodies from products such as blood derivatives (eg, plasma protein), freeze dried eggs containing pig related antibodies and possibly some whey protein products. Reduced immune activity promotes growth by increasing appetite and partitioning nutrients to growth.

Endless List
There is not time to review the considerable list of other products shown to have some antimicrobial activity. Failure to mention them in this paper should not be taken as a negative inference.

Supportive Dietary Modification
This bacteriostatic approach is supported by alteration to the diet to reduce the amount of substrate available to the intestinal microflora. Diets must be modified to reduce “By-Pass Nutrients”! This is best achieved through increased digestibility of ingredients used or by the addition of enzymes to less digestible ingredients. The aim is to reduce the protein and carbohydrate fraction of the diet which can escape digestion and absorption by the pig and remain available as a food source for microbial fermentation by intestinal microflora. Bacterial fermentation of indigestible protein produces ammonia and biogenic amines which are toxic and increase the risk of diarrhoea. Piglet starter diets are highly digestible and may encourage a shift to protein fermentation in the hind gut by being ‘carbohydrate’ deficient. The addition of fermentable carbohydrates (prebiotics) to pig diets has been shown to reduce protein fermentation through increased carbohydrate fermentation in the hind gut. The reduced efficiency of bile salts can be countered by adding emulsifying agents (lecithin) directly to the diet and by improving the saturated to unsaturated fatty acid ratio in the diet to aid absorption. Alterations such as switching from DL-Methionine to Liquid MHA-FA, an organic acid, is another small change which can increase the antimicrobial status of a pig diet. The efficiency of the intestinal epithelium structure and function can be upgraded with the use of Betaine

War of Attrition – The search for an AGP Replacer
Primary Diets set out in 1998 to produce an ‘all weather’ product through multiple studies. No “eureka” breakthrough. No high science, but thorough science. We used the University of Leeds to apply rigorous scientific methods to build up a database of growth and FCR responses using several commercially available products from each additive category thought to reduce intestinal microflora. We compared several organic acid products, several essential oils, several prebiotics and so on until we had identified what pigs showed to be the superior products when used within our diets. Then we began combining the winners of each category to test for additivity. After six years this pedestrian but methodical approach has produced a product with a high probability of success in a wide variety of circumstances.

Field Validation
The most successful combination product, according to JSR pigs at the University of Leeds was then compared with a positive control on four large commercial herds with varying degrees of disease challenge and one large, high health herd, against a negative control. These large scale trials can do little more than increase the confidence and comfort factor, as scientific rigour is not available at farm level (no attempt to balance litter of origin across treatment, no access to negative and positive controls against treatment). The apparent consistency of response at farm level during 2004 led us to introduce the product to JSR units at the beginning of 2005. JSR set us the target of having in place, by the end of 2004, the AGP replacer which we would utilise on commercial units in 2006. The aim was to be selecting JSR genetic stock, from pigs fed on a 2006 AGP replacer, throughout 2005. The JSR male and female lines available to UK pig producers in 2006 will have been selected throughout 2005 on test diets containing a 2006 AGP replacer.

Future Progress
What we now have are rather crude products which will efficiently bridge the gap between AGP’s and a new generation of products being developed with the aid of molecular biology. Until recently the microbial community of the intestine has been studied by cultivating commensal bacterial and opportunistic pathogens. Most anaerobic intestinal bacterial are very difficult to cultivate and remain unidentifiable by conventional techniques. Recently a breakthrough has been made in this area by phylogenetic analysis based on the in vitro amplification of the 16s r RNA gene and other phylogenetic markers by polymerase chain reaction (PCR) techniques. (Awati, A, 2005). These have revealed dramatically higher diversity of the intestinal microflora compared to those described by cultivation. A combination of PCR and fingerprinting techniques such as denaturing gradient gel electrophoresis (DGGE) and terminal restriction fragment length polymorphism (T-RFLP) offer opportunities for a great leap forward in our understanding of intestinal microbial populations and for the first time, rapid methods of assessing the effects of different additives and dietary strategies. (Awati, A, 2005). In addition, laboratory models of the GI tract are now sufficiently sophisiticated to allow them to be used to study AGP replacers.

Intestinal Genomics
Gene expression profiling holds tremendous promise for dissecting the regulatory mechanisms of complex biological processes, yet relatively little work is being done with livestock animals despite the fundamental importance of the intestines to production animals. Genomic analysis offers the possibility to identify mechanisms and pathways which allow for a rational design of AGP replacers. It may now be possible to achieve in months what we have achieved in years of pig feeding trials.

Take Veterinary Advice
The challenge for pig producers is not to understand the mode of action of AGP replacers, but to find suitable, reliable and cost effective management routines and feed additives for a sustainable and successful pig production. Health and hygiene will be key to success without AGP’s. There could not be a better time to agree or review a health plan for each pig unit with the veterinary surgeon. Cleaning and disinfection routines should also be reviewed and upgraded if required. The quality of stockmanship and pig management is also fundamentally important in tackling post weaning growth performance and post weaning diarrhoea. Long before Dr Francois Madec became associated with PMWS, he was well known for his classic work on defeating post weaning diarrhoea through improved management and stockmanship. (Madec, F, 1999). Improved stockmanship is one of the more successful AGP replacers. Everyone should have read and acted on the advise set out in the BPEX/MLC booklet “Managing the Withdrawal of Antibiotic Growth Promoters from Pig Feeds”.

Global Problem
The removal of AGP’s in Denmark has led to a dramatic fall in resistance to Avoparcin/Vanomycin in the intestinal bacterial of Danish livestock, but no effect has yet been recorded in the human population (the main point of the exercise!). Studies by the Danish Institute for Food and Veterinary Research (DFVF) have found that imported meat products contained bacteria up to seven times more resistant to antibiotics than those found in Danish meat products. Nine out of ten Danes infected with multi-resistant bacteria have been shown to have contracted the original infection from imported meat. We may reduce the reservoir of antibiotic resistant genes in EU livestock, but that is unlikely to have any impact on the reservoir in humans, while relatively free trade on meat products exists.

Summary
The removal of AGP’s increases the cost of production by 40p per weaner and 60p - £1.80 per slaughter pig. AGP’s are thought to have altered the intestinal bacterial population in a way that yielded benefits from intestine-bacteria interactions, which resulted in improved pig performance. A failure to replace AGP’s will result in an increase in adverse intestine-bacteria interactions. Bacteria are important in the regulation of the intestinal function and immunity. Bacteria have a direct influence of the genetic programming of the intestines through direct association with the intestinal cell surfaces. Bacteria communicate with mucosal epithelial cells and modulate cytokine profiles. The expansion and function of the immune system necessitates exposure to bacterial antigens. Dietary additives, nutritional modifications and improved farm hygiene and management can prevent performance and economic loss when antibiotic growth promoters (AGP’s) are removed at the end of 2005. Antibiotic resistant gene reservoirs will diminish in EU livestock but this is not expected to have any impact on antibiotic resistant gene reservoirs in the EU human population, as a sufficient and increasing proportion consume imported meat products.

References
A list of references is available from gail.rowley@jsr.co.uk

Awati, A. (2005). Prebiotics in piglet nutrition? PhD Thesis. Animal Nutrition Group, Wageningen Institute of Animal Science.

Bartel, S M, et al. (2004). Poult, Sci 83. (Supp 1):265.

Bedford, M. (2005). Antimicrobial Growth Promoters. Worldwide Ban on the Horizon. p 49.

Bedford, M et al. (1998). Nutrition Research Reviews. 11:91-114.

Bikker, P et al. (2005). Feed Mix vol 13. No. 2. P12-13.

Corrent, S. (2002). Nutreco trial report, p 172.

Carrol, J A et al. (2000). Domestic Animal Endocrinology. 19:39-52.

Decuypere, J. (2003). Western Nutrition Conference. Canada.

Gardiner, G E et al (2004). Applied and Environmental Microbiology. 70: 1895 – 1906.

Gaskins, H R. (2001). P 585. In Lewis AJ, Southern LL. Ed. Swine Nutrition. 2 ed CRC press. Boca Raton.

Geldek, B (1993). Internal Report, BASF. AG Ludwigzhafen, Germany.

Hooper LV et al. (2002). Annu Rev Nutr 22:283-307.

Huff, G R et al. (2005). Antimicrobial Growth Promoters. Worldwide Ban on the Horizon. p 120.

Janroz, D. (2003). Journal of Animal and Feed Science. 12:583-596.

Kalliomaki, M et al. (2001). J Allergy and Clinical Immunology. Jan 129-134.

Kettunen, H et al. (2001). Comparative Biochemistry and Physiology. Part A:Molecular and Integrative Physiology 130 : 759-769.

Madec, F et al. (1999). Manipulating Pig Production 7. p 200-209

Miller, H et al. (2005). Journal of Animal Science Supp. Vol 83. Supp 1: p 296

Morales, R et al. (2005). Antimicrobial Growth Promoters. Worldwide Ban on the Horizon. p102.

Naughton, P J et al. (2001). Appl Environ Microbiol. 67:3391-3395.

Nurminen, P et al. (2005). Antimicrobial Growth Promoters. Worldwide Ban on the Horizon. p114.

Oostenbach, P J G (2005). Antimicrobial Growth Promoters. Worldwide Ban on the Horizon. p92. AGP@bastiaanse-communication.com

Partenen et al. (1999). Nutrition Research Review. 12: 117-145.

Pouillard, P. (2003). International Forum Agrosante 2003, 1-2 April.

Semann, B et al. (2003). J Allergy and Clinical Immunology. 111:1069-1075.

Shirkley, T W et al. (2003). 9th International symposium on Digestive Physiology in Pigs. 2:290-292.

Siggers, RG et al. (2003). 9th International symposium on Digestive Physiology in Pigs. 2:13-15.

Simon, O (2004). In L Tucker and JA Pickard (eds). Interfacing immunity, gut health and performance. pp 33-46. Nottingham University Press.

Spring, P et al (2000). Poultry Science. 79:205-211.

Asian-Australian Journal of Animal Science. 16:282-289.

Witte, W. (2000). International Journal of Antimicrobial Agents. Suppl 1: 519-524.

LIKE TO PRINT THIS ARTICLE?